These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3861236)

  • 1. Karyotypic evolution in Ph-positive chronic myeloid leukemia in relation to management and disease progression.
    Swolin B; Weinfeld A; Westin J; Waldenström J; Magnusson B
    Cancer Genet Cytogenet; 1985 Sep; 18(1):65-79. PubMed ID: 3861236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome changes and splenectomy in Ph-positive CML. III. Predictive parameters in the chronic phase.
    Sadamori N; Sandberg AA
    Cancer Genet Cytogenet; 1985 Jan; 14(3-4):227-34. PubMed ID: 3855366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome changes and splenectomy in Ph1-positive chronic myeloid leukemia. I. Predictive parameters in the blastic phase.
    Sadamori N; Sandberg AA
    Cancer; 1984 Dec; 54(11):2456-9. PubMed ID: 6594187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of abnormal clone of leukaemic cells by splenectomy.
    Gomez G; Hossfeld DK; Sokal JE
    Br Med J; 1975 May; 2(5968):421-3. PubMed ID: 1055011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-random karyotypic evolution in chronic myeloid leukemia.
    Mitelman F; Levan G; Nilsson PG; Brandt L
    Int J Cancer; 1976 Jul; 18(1):24-30. PubMed ID: 1065618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. t(1;2), inv(1) and trisomy 1q during the blastic phase of Philadelphia chromosome-positive chronic myeloid leukemia.
    Carbone P; Barbata G; Santoro A; Giglio MC; Mirto S; Granata G
    Acta Haematol; 1987; 77(4):198-202. PubMed ID: 3115029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal characteristics of chronic and blastic phases of Ph-positive chronic myeloid leukemia.
    Sadamori N; Matsunaga M; Yao E; Ichimaru M; Sandberg AA
    Cancer Genet Cytogenet; 1985 Feb; 15(1-2):17-24. PubMed ID: 3855376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chromosomal abnormalities of the blastic phase of chronic myeloid leukemia].
    Stoll C
    Pathol Biol (Paris); 1982 Nov; 30(9):755-8. PubMed ID: 6760078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic granulocytic leukemia: correlation of blastic transformation type with karyotypic evolution.
    O'Malley FM; Garson OM
    Am J Hematol; 1985 Dec; 20(4):313-23. PubMed ID: 3865531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic studies of bone marrow and extramedullary tissues and clinical course during metamorphosis of chronic myelocytic leukemia.
    Swolin B; Weinfeld A; Waldenström J; Westin J
    Cancer Genet Cytogenet; 1983 Jul; 9(3):197-209. PubMed ID: 6574810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different cell clones in bone marrow and spleen of a patient with chronic myelocytic leukemia (CML) in blastic phase.
    Olinici CD; Petrov L; Macavei I; Dobay O
    Cancer; 1978 Dec; 42(6):2707-9. PubMed ID: 282004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome changes and splenectomy in Ph1-positive CML. II. Prognostic aspects in the blastic phase.
    Sadamori N; Sandberg AA
    Cancer Genet Cytogenet; 1984 Aug; 12(4):303-8. PubMed ID: 6589034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic follow-up in chronic myeloid leukemia.
    Hartley SE; McBeath S
    Cancer Genet Cytogenet; 1981 Jan; 3(1):37-46. PubMed ID: 6944150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal evolution of karyotype in blastic phase of CML.
    Izakovic V; Horák I; Krizan P
    Neoplasma; 1982; 29(5):613-23. PubMed ID: 6960260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of secondary cytogenetic changes in patients with Ph-positive chronic granulocytic leukemia in the acute phase.
    Singh S; Wass J; Vincent PC; Young GA; Gunz FW
    Cancer Genet Cytogenet; 1986 Apr; 21(3):209-20. PubMed ID: 3456261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to the therapy of chronic granulocytic leukemia.
    Spiers AS
    Ser Haematol; 1975; 8(4):157-73. PubMed ID: 798284
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations.
    Mohamed AN; Pemberton P; Zonder J; Schiffer CA
    Clin Cancer Res; 2003 Apr; 9(4):1333-7. PubMed ID: 12684401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytogenetics of chronic granulocytic leukaemia.
    Lawler SD
    Clin Haematol; 1977 Feb; 6(1):55-75. PubMed ID: 334417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloproliferative disorders: II CML: clonal evolution and its role in management.
    Brodsky I; Fuscaldo KE; Kahn SB; Conroy JF
    Leuk Res; 1979; 3(6):379-93. PubMed ID: 297175
    [No Abstract]   [Full Text] [Related]  

  • 20. Additional Philadelphia chromosomes in acute blastic crisis of chronic myelocytic leukemia: possible mechanism of producing additional chromosomal abnormalities.
    Goh KO
    Am J Med Sci; 1974 Apr; 267(4):229-40. PubMed ID: 4526171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.